By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – BioTime today announced that its majority-owned subsidiary OncoCyte has received $10 million in a new round of equity financing, which it will use to further develop diagnostics and therapeutics for cancer.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.
A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.
Researchers report that paternally inherited genes are more likely to be expressed in mice.
National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.